Outcome of Preferential Issue Committee meeting held on Friday, 4th September, 2026, as per Regulation 30 of…
As filed · Outcome of Preferential Issue Committee meeting held on Friday, 4th September, 2026, as per Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Re
What happened
FactOutcome of Preferential Issue Committee meeting held on Friday, 4th September, 2026, as per Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Outcome of Preferential Issue Committee meeting held on Friday, 4th September, 2026. Outcome of the Board Meeting held on Friday, July 10, 2026, and Preferential Issue.
Why it matters
CapitSignal interpretationShares are issued to named investors at a set price, diluting existing holders and changing who sits on the register.
What management said before
Prior statements by this company that CapitSignal has recorded changing.
Demand
DelayedIn the second quarter we are expecting a major push from Arrotex on that Macrogol new molecule which we launched.
And in third and fourth quarter we see a lot of progress coming from Ibuprofen and Clarithromycin granules.
Change
FactImplication
CapitSignal interpretationWatch next
Fact- Who the allottees are
- Issue price versus market price
- Lock-in period on the new shares
- We expect FY27 to witness revenue growth of more than 50%. (management committed by FY27)
- A key milestone was the commercialization of the Viatris (USA), Manx (UK) and Arrotex (Australia) CDMO partner (management committed by FY27)
Evidence
- Outcome of Preferential Issue Committee meeting held on Friday, 4th September, 2026, as per Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.(opens the original filing in a new tab)
- Earlier statement · Q1 FY27
- Latest statement · Q1 FY27
- Earlier statement · Q1 FY27
How CapitSignal classified this
- Reasoning:
- PREFERENTIAL_ALLOTMENT base 66; +5 quantified amount; matched on subject
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 75%